A Response to: Letter to the Editor Regarding 'Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of Age'

被引：1
|
作者：
Rozenbaum, Mark H. [1 ]
Perdrizet, Johnna [2 ]
Li, Xiuyan [2 ]
Wasserman, Matt D. [3 ]
Grant, Lindsay R. [4 ]
Hayford, Kyla [4 ]
Farkouh, Raymond A. [1 ]
机构：
[1] Pfizer, Hlth Econom & Outcomes Res, Capelle Aan Den Ijssel, Netherlands
[2] Pfizer Inc, Hlth Econom & Outcomes Res, New York, NY USA
[3] Pfizer Inc, Patient & Hlth Impact, New York, NY USA
[4] Pfizer Inc, Vaccines Med Dev & Sci & Clin Affairs, New York, NY USA
来源：
INFECTIOUS DISEASES AND THERAPY | 2023年 / 12卷 / 01期
关键词：
COST-EFFECTIVENESS; VACCINATION;
D O I：
10.1007/s40121-022-00719-4
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：295 / 298
页数：4
相关论文
共 40 条
  • [21] Response to Letter to the Editor regarding: Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 18-49 years of age, naive to 23-valent pneumococcal polysaccharide vaccine
    Bryant, Kristina
    Frenck, Robert W., Jr.
    VACCINE, 2016, 34 (38) : 4467 - 4467
  • [22] Impact and effectiveness of the 10-valent pneumococcal conjugate vaccine on invasive pneumococcal disease among children under 5 years of age in the Netherlands
    Peckeu, L.
    van der Ende, A.
    de Melker, H. E.
    Sanders, E. A. M.
    Knol, M. J.
    VACCINE, 2021, 39 (02) : 431 - 437
  • [23] Economic burden of pneumococcal infections in children under 5 years of age (vol 14, pg 106, 2018)
    Ceyhan, Mehmet
    Ozsurekci, Yasemin
    Aykac, Kubra
    Hacibedel, Basak
    Ozbilgili, Egemen
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (07) : 2350 - 2350
  • [24] Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and X-ray defined pneumonia in children less than two years of age
    Lucero, Marilla G.
    Dulalia, Vernoni E.
    Nillos, Leilani T.
    Williams, Gail
    Parrefio, Rhea Angela N.
    Nohynek, Hanna
    Riley, Ian D.
    Makela, Helena
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (04):
  • [25] Impact of 10-and 13-valent pneumococcal conjugate vaccines on incidence of invasive pneumococcal disease in children aged under 16 years in Germany, 2009 to 2012
    Weiss, S.
    Falkenhorst, G.
    van der Linden, M.
    Imoehl, M.
    von Kries, R.
    EUROSURVEILLANCE, 2015, 20 (10):
  • [26] Economic burden of acute otitis media, pneumonia, and invasive pneumococcal disease in children in the United States after the introduction of 13-valent pneumococcal conjugate vaccines during 2014–2018
    Tianyan Hu
    Yan Song
    Nicolae Done
    Salini Mohanty
    Qing Liu
    Eric M. Sarpong
    Esteban Lemus-Wirtz
    James Signorovitch
    Thomas Weiss
    BMC Health Services Research, 23
  • [27] Streptococcus pneumoniae Serotypes Causing Invasive Disease in Children Under 5 Years of Age After the Introduction of the Pneumococcal 13-Valent Conjugate Vaccine in El Salvador
    Marin, Jose Eduardo Oliva
    Villatoro, Luis Guillermo Castaneda
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2023, 42 (10) : E398 - E399
  • [28] Economic burden of acute otitis media, pneumonia, and invasive pneumococcal disease in children in the United States after the introduction of 13-valent pneumococcal conjugate vaccines during 2014-2018
    Hu, Tianyan
    Song, Yan
    Done, Nicolae
    Mohanty, Salini
    Liu, Qing
    Sarpong, Eric M.
    Lemus-Wirtz, Esteban
    Signorovitch, James
    Weiss, Thomas
    BMC HEALTH SERVICES RESEARCH, 2023, 23 (01)
  • [29] Serotypes and antimicrobial resistance of Streptococcus pneumoniae in children under 5 years of age pre- and post-pneumococcal conjugate vaccine introduction in Paraguay
    Leon, Maria Eugenia
    Samudio, Margarita
    Kawabata, Anibal
    Nagai, Minako
    Rojas, Liliana
    Zarate, Noemi
    Irala, Juan
    Leguizamon, Myrian
    Gomez, Gloria
    Ortellado, Juana
    Blasco, Raquel
    Franco, Rossana
    Chamorro, Gustavo
    JOURNAL OF MEDICAL MICROBIOLOGY, 2023, 72 (06)
  • [30] COST-UTILITY ANALYSIS OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN THE IMMUNIZATION OF CHILDREN UNDER FIVE YEARS FOR THE PREVENTION OF INVASIVE PNEUMOCOCCAL DISEASE AND PNEUMONIA IN THE BRAZILIAN PUBLIC HEALTHCARE SYSTEM
    Alexandre, R. F.
    Almeida, P.
    Sebastiao, M.
    Ferreira, P.
    Senna, T.
    VALUE IN HEALTH, 2023, 26 (06) : S77 - S77
1234